All Outcomes
Home COVID-19 treatment researchSeleniumSelenium (more..)
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta
Cannabidiol Meta Molnupiravir Meta
Colchicine Meta
Conv. Plasma Meta
Curcumin Meta Nigella Sativa Meta
Ensovibep Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Peg.. Lambda Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Ivermectin Meta
Lactoferrin Meta


Supplementary Data — Selenium for COVID-19: real-time meta analysis of 9 studies (3 treatment studies and 6 sufficiency studies)

@CovidAnalysis, October 2023
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ COVIDENCE UK Holt 80% 0.20 [0.03-1.44] cases 1/167 445/15,060 Improvement, RR [CI] Treatment Control Nimer -26% 1.26 [0.64-2.32] hosp. 12/57 207/2,091 Nimer -9% 1.09 [0.57-1.97] severe case 12/57 248/2,091 Vaisi 53% 0.47 [0.32-0.81] hosp. 3,853 (n) 102 (n) Vaisi 15% 0.85 [0.40-0.97] symp. case 3,853 (n) 102 (n) Selenium COVID-19 outcomes October 2023 Favors selenium Favors control
Figure S1. All outcomes.
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop